Aptamers as Theragnostic Tools in Prostate Cancer

Aptamers as Theragnostic Tools in Prostate Cancer

Despite of the capacity that several drugs have for specific inhibition of the androgen receptor (AR), in most cases, PCa progresses to an androgen-independent stage. In this context, the development of new targeted therapies for prostate cancer (PCa) has remained as a challenge. To overcome this is...

Full description

Bibliographic Details
Main Authors: Carlos David Cruz-Hernández, Griselda Rodríguez-Martínez, Sergio A. Cortés-Ramírez, Miguel Morales-Pacheco, Marian Cruz-Burgos, Alberto Losada-García, Juan Pablo Reyes-Grajeda, Imelda González-Ramírez, Vanessa González-Covarrubias, Ignacio Camacho-Arroyo, Marco Cerbón, Mauricio Rodríguez-Dorantes
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomolecules
Subjects:
prostate cancer
aptamers
Prostate-Specific Membrane Antigen (PSMA)
Prostate-Specific Antigen (PSA)
PCa diagnosis
PCa treatment
Online Access:https://www.mdpi.com/2218-273X/12/8/1056

Internet

https://www.mdpi.com/2218-273X/12/8/1056

Similar Items